ALHCHealthcare · Healthcare PlansThe 14 Wall Street analysts covering Alignment Healthcare, Inc. hold a median 12-month price target of $11 — +33.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 60 of 100 as at 14 Oct 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores Alignment Healthcare, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Growth (82): Sales and profits are climbing, and climbing faster than before.
Momentum (21): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on ALHC, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +33.7% from it.
Of the 20 most recent actions, 0 moved their price target up and 6 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 9 Oct 2026 | JP Morgan | Maintains | Overweight | $22 → $10 |
| 9 Oct 2026 | Keybanc | Maintains | Overweight | $28 → $12 |
| 9 Oct 2026 | William Blair | Downgrade | Market Perform | — |
| 6 Oct 2026 | Barclays | Maintains | Equal-Weight | $16 → $10 |
| 4 Aug 2026 | JP Morgan | Maintains | Overweight | — |
| 4 Aug 2026 | JP Morgan | Maintains | Overweight | $26 → $22 |
| 3 Aug 2026 | Raymond James | Downgrade | Outperform | — |
| 3 Aug 2026 | Raymond James | Downgrade | Outperform | $22 → $19 |
| 26 May 2026 | Barclays | Maintains | Equal-Weight | $19 → $16 |
| 26 May 2026 | Barclays | Maintains | Equal-Weight | — |
| 1 May 2026 | Barclays | Maintains | Equal-Weight | — |
| 1 May 2026 | UBS | Maintains | Neutral | — |
| 5 Feb 2026 | JP Morgan | Maintains | Overweight | — |
| 16 Jan 2026 | TD Cowen | Maintains | Buy | — |
| 14 Jan 2026 | UBS | Maintains | Neutral | — |
| 6 Jan 2026 | Piper Sandler | Maintains | Overweight | — |
| 17 Dec 2025 | JP Morgan | Maintains | Overweight | — |
| 24 Nov 2025 | JP Morgan | Upgrade | Overweight | — |
| 5 Nov 2025 | JP Morgan | Maintains | Neutral | — |
| 3 Nov 2025 | Barclays | Maintains | Equal-Weight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ALHC appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 14 Oct 2026, Alignment Healthcare, Inc. returned −52.3% against +17.5% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 17% of US stocks
Cheaper than 86% of US stocks
Cheaper than 15% of US stocks
Cheaper than 22% of US stocks
Higher than 78% of US stocks
Higher than 87% of US stocks
Higher than 13% of US stocks
Higher than 51% of US stocks
Higher than 49% of US stocks
Higher than 81% of US stocks
Higher than 66% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Alignment Healthcare, Inc. has a market value of $1.7B and an enterprise value of $1.4B.
Revenue in the twelve months to 30 June 2026: $4.6B. The latest quarter grew 31.6% year on year.
Net income over the same four quarters: $40.7M, a 0.9% net margin.
Diluted earnings per share, trailing twelve months: $0.19.
Free cash flow in the twelve months to 30 June 2026: $177.5M.
Trailing P/E: 43.7×; forward P/E: 12.8× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Alignment Healthcare, Inc. employs 1,849 people — $2.5M of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
| Company | Market cap | TKN rank |
|---|---|---|
| ALHCAlignment Healthcare, Inc. | $1.7B | 60 |
| PGNYProgyny, Inc. | $2.2B | 97 |
| CLOVClover Health Investments Corp. | $2.5B | 72 |
| OSCROscar Health, Inc. | $10.2B | 91 |
| MOHMolina Healthcare, Inc. | $10.8B | 36 |
| ESTAEstablishment Labs Holdings, Inc.* | $1.7B | 74 |
| XRAYDentsply Sirona, Inc.* | $1.7B | 89 |
* Nearest Healthcare names by size — few healthcare plans companies of this scale trade in the US universe.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Alignment Healthcare, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
The Law Offices of Frank R. Cruz said it continues to investigate Alignment Healthcare on behalf of investors over possible violations of federal securities laws.
Why it matters — ALHC watchers may wish to note the ongoing investigation concerning the company and its investors.
CMS lowered Alignment Healthcare’s 2027 Star Rating for its California HMO contract, H3815, from 4.0 to 3.5 stars. The excerpt says the rating change followed investor concerns about the contract’s performance and CMS cut points.
Why it matters — H3815 serves 75% of Alignment’s health plan membership, making its rating and related CMS eligibility scrutiny relevant to ALHC watchers.
The article compares CVS Health with Alignment Healthcare, saying CVS has stronger returns, rising earnings estimates and a lower valuation as Aetna’s turnaround gains traction.
Why it matters — It presents CVS more favorably than ALHC on these measures, providing a comparison for investors following Alignment Healthcare.
Alignment Healthcare said it will release its third-quarter 2026 financial results after market close on Thursday, Oct. 29, 2026, and host a conference call.
Why it matters — ALHC watchers can note the date when the company plans to report results and discuss them on a call.
Block & Leviton said it is investigating Alignment Healthcare for potential securities law violations. The firm invited investors who lost money in ALHC to contact it about possible recovery of losses.
Why it matters — The investigation and outreach to investors concern potential securities-law issues related to Alignment Healthcare.
The 14 Wall Street analysts covering Alignment Healthcare, Inc. have a median 12-month price target of $11, with estimates ranging from $9 to $26. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 14 analysts covering Alignment Healthcare, Inc., 10 rate it a Buy, 4 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Alignment Healthcare, Inc. 60 out of 100 across roughly 4,600 US stocks as at 14 Oct 2026. None of this is personal advice — it does not consider your circumstances.
As at 14 Oct 2026, Alignment Healthcare, Inc. ranks 60 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Growth (82 of 100).
No one can know that. What the data says: the median 12-month target from 14 analysts implies +33.7% from the last close, and Ticker Nerd's factor model ranks Alignment Healthcare, Inc. 60 out of 100 as at 14 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Alignment Healthcare, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ALHC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $9 to $26 over the next 12 months.
Alignment Healthcare, Inc. returned -52.3% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.
Alignment Healthcare, Inc. is a managed healthcare company focused on Medicare Advantage plans for seniors in the United States.
The most recent item we track (GlobeNewsWire, 14 Oct 2026): "Securities Fraud Investigation Into Alignment Healthcare, Inc. (ALHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz". The Law Offices of Frank R. Cruz said it continues to investigate Alignment Healthcare on behalf of investors over possible violations of federal securities laws.
Alignment Healthcare, Inc. is a managed healthcare company focused on Medicare Advantage plans for seniors in the United States. The company provides a consumer-centric healthcare platform designed to coordinate coverage and care through customized health plan offerings, local provider partnerships, and technology-enabled support. Its services are built to help members navigate benefits, access care, and manage their health through tools such as member portals, mobile apps, concierge-style assistance, and care coordination resources. Alignment Healthcare serves seniors and Medicare beneficiaries in selected U.S. markets, with a business model centered on improving the experience of health plan members while working closely with providers and care teams. Headquartered in Orange, California, Alignment Healthcare plays a specialized role in the managed care sector by combining insurance coverage with clinical and digital support services.
CEO Mr. John E. Kao · 1,849 employees · United States · https://www.alignmenthealth.com
